GCC Wound Closure Devices Market Key Takeaways

• The GCC Wound Closure Devices market, valued at USD 551 million in 2025, to USD 583 million in 2026 and is projected to reach USD 778 million by 2032.
• The industry is projected to witness steady growth at a CAGR of 4.93% during 2026-32.
• Saudi Arabia dominates the regional landscape with approximately 39% market share.
• Absorbable sutures lead the product segment with a 70% share.
• General surgery accounts for 35% of application-based demand in 2026.
• The market remains highly fragmented, with the top five companies collectively holding only 22% share.

GCC Wound Closure Devices Market Size and Outlook

The wound closure devices market in GCC, valued at USD 551 million in 2025, to USD 583 million in 2026 and is projected to reach USD 778 million by 2032, expanding at a CAGR of 4.93%. i.e., during the forecast period of 2026-32.

This growth is underpinned by a structural expansion of surgical infrastructure across the six GCC states, driven by sustained government investment in hospital capacity, a sharp rise in chronic disease burden requiring operative intervention, and the progressive rollout of mandatory health insurance coverage that is bringing previously uninsured populations into formal surgical care pathways.

Saudi Arabia accounts for the single largest share of regional demand, a position anchored by the Kingdom's Health Sector Transformation Program under Vision 2030. The Saudi government allocated USD 69.3 billion to the health and social development sector and committed to opening five new hospitals in 2025, adding 963 beds across Rijal Alma, Dhahran Al-Janoub, Hail, Makkah, and Riyadh. Saudi Arabia currently offers approximately 2.26 hospital beds per 1,000 people below the G20 emerging economy average of 2.85, and requires an additional 27,000 beds by 2030 to meet projected demand. Each bed added to the system represents a direct expansion in surgical throughput, and every surgical episode generates demand for sutures, staples, or advanced wound closure consumables.

The UAE is accelerating demand through insurance-driven access reform. Effective January 1, 2025, the UAE Cabinet extended mandatory health insurance to private-sector employees and domestic workers across all seven emirates, including the five Northern Emirates previously excluded from coverage requirements. This policy expands insured access to elective and semi-elective surgical procedures, creating a measurable uplift in suture and wound closure device consumption. Healthcare spending in the UAE is projected to reach USD 6.63 billion by 2032, with public sector expenditure growing at a CAGR of 10% and private sector.

Chronically elevated disease prevalence across the GCC is a structural demand multiplier. According to the IDF Diabetes Atlas 11th Edition, Saudi Arabia and Kuwait rank among the ten countries globally with the highest projected type 1 diabetes incidence in children under 15 years in 2024, while the wider Middle East and North Africa region records among the world's fastest-growing diabetes burdens.

 Diabetic complications, including vascular, orthopedic, and wound-care procedures, place disproportionate demand on sutures and closure systems relative to surgical volume in lower-prevalence regions. Against this backdrop of expanding infrastructure, insurance-broadened access, and high operative disease rates, the market is positioned for sustained above-average growth through 2032.

GCC Wound Closure Devices Key Indicators

• According to the IDF Diabetes Atlas 11th Edition (2024), Kuwait records an age-standardized diabetes prevalence of 25.6% among adults aged 20–79 years, the third highest globally; diabetic patients face elevated rates of peripheral vascular, wound care, and orthopedic surgical procedures, sustaining disproportionate per-capita demand for absorbable sutures and closure consumables relative to the general surgical population.
• According to Qatar's Ministry of Finance, the government allocated USD 6.04 billion to healthcare in its 2025 national budget, representing 10.5% of total government expenditure; dedicated capital for hospital infrastructure directly commissions operating theatres and inpatient surgical capacity. Thereby, each new facility generates sustained baseline procurement demand for sterile wound closure consumables.
• According to the Dubai Health Authority (DHA), the number of licensed healthcare facilities in Dubai grew to approximately 5,800 in 2025 from 5,340 in 2024, an increase of over 8%, including 55 hospitals and 60 day-surgery centres. Therefore, each newly commissioned surgical facility expands operative throughput capacity and generates baseline annual procurement demand for sterile sutures and wound closure consumables.
• According to the UAE Ministry of Interior's open data, the UAE recorded 384 road fatalities and 6,032 injuries of varying severity in 2024, an 8% increase in accidents and a 9% rise in fatalities compared to 2023, with major accidents rising a further 23% to 6,014 cases in 2025. The trauma surgical procedures required to treat laceration, fracture, and soft-tissue injuries from road accidents generate direct, volume-driven demand for sutures and wound closure consumables across emergency and operating theatre settings across GCC hospitals.

GCC Wound Closure Devices Market Scope

Category	Segments
By Product	Surgical Staplers, Tissue Adhesives & Sealants, Wound Closure Strips, Surgical Clips, Surgical Sutures (Absorbable Sutures (Polyglactin 910 Sutures (Vicryl type), Polyglycolic Acid (PGA) Sutures, Poliglecaprone 25 Sutures (Monocryl type), Polydioxanone (PDO/PDS) Sutures, Catgut Sutures (Plain Catgut, Chromic Catgut)), Non-Absorbable Sutures (Silk Sutures, Nylon Sutures, Polypropylene Sutures (Prolene type), Polyester Sutures, Stainless Steel Sutures)), Others
By Application	General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gynecological & Obstetric Surgery, Ophthalmic Surgery, Cosmetic & Plastic Surgery, Neurological Surgery, Others
By End User	Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others

GCC Wound Closure Devices Market Growth Drivers

Growing Medical Tourism Driving Demand for Surgical Sutures and Wound Closure Devices Across GCC

Medical tourism is a direct, additive demand driver for the GCC wound closure devices market. Every international patient who travels to the region for a surgical procedure, whether cardiac, orthopedic, cosmetic, or bariatric, requires the same sutures and closure consumables as a domestically treated patient, adding incremental operative caseload on top of resident surgical volumes.

Countries like Saudi Arabia's privatization programme quantifies this shift concretely. According to the U.S. Commercial Service Country Commercial Guide, the Kingdom's Vision 2030 commits over USD 65 billion to healthcare infrastructure development GCC-wide, targeting the privatization of 290 hospitals and 2,300 primary health centers, with the private sector's share of healthcare delivery rising from 40% to 65% by 2030.

 In Qatar, Hamad Medical Corporation performed over 60,090 surgeries in 2023 and recorded more than 3 million outpatient visits in 2024, a 24% increase in the second half of the year as per official HMC statistics published in January 2025.

As GCC hospitals scale inbound surgical capacity and attract international patients through accreditation and visa facilitation, rising operative volumes will sustain growing procurement demand for surgical sutures and wound closure devices across the region through 2032.

Recent Trends

Rising Adoption of Advanced Wound Closure Devices Over Conventional Suturing Techniques

GCC hospitals are actively replacing conventional hand-sewn sutures with advanced wound closure products, GCC region-wide, particularly surgical staplers and next-generation tissue adhesives. This shift is driven by faster operating times, lower infection risk, and compatibility with minimally invasive and robotic procedures, priorities that align directly with the region's push to improve surgical outcomes and reduce hospital stays.

Two major product launches in 2025 and 2026 reflect how manufacturers are responding to this demand. In June 2025, Johnson & Johnson launched the ETHICON™ 4000 Stapler featuring proprietary 3D Staple Technology, which reduces staple line leaks and bleeding complications across bariatric, colorectal, and thoracic procedures; the system received CE Mark approval in April 2026, opening the SFDA-aligned regulatory pathway for GCC market entry.

 Similarly, in November 2025, Medtronic launched the Signia™ Circular Stapler with Tri-Staple™ technology, the first intelligent circular stapling system with real-time tissue feedback, with its official press release explicitly listing the Middle East among its target regional markets. As GCC surgical sutures market procurement standards continue to evolve, demand for advanced wound closure technologies that GCC hospitals adopt will accelerate through 2032.

GCC Wound Closure Devices Market Opportunities and Challenges

High Import Dependency on Surgical Consumables Creating Pressure for Local Manufacturing in GCC

The GCC wound closure devices market depends almost entirely on imports, leaving hospitals vulnerable to supply disruptions, price volatility, and, most critically, procurement exclusion. For instance, Saudi Arabia's National Unified Procurement Company (NUPCO) made this risk concrete under its 2026 tender framework, only SFDA-licensed, locally manufactured products qualify for government hospital contracts, directly shutting out foreign manufacturers supplying entirely through imports.

This pressure, however, is simultaneously creating a major commercial opportunity for manufacturers who invest in GCC-based production. In February 2025, Mölnlycke Health Care officially inaugurated Tamer Mölnlycke Care in Jeddah, opened by Saudi Minister of Health Fahad Al-Jalajel, expanding its ownership to 60% and commencing factory production of wound care products and surgical procedure trays for distribution across the GCC and MENA. Manufacturers establishing in-Kingdom production gain NUPCO tender eligibility, Vision 2030 localization compliance, and long-term procurement positioning across the region's expanding hospital network through 2032.

Segmentation Insights

Growing Bariatric and Abdominal Surgery Volumes Drive Absorbable Sutures to Market Leadership Across the GCC

Absorbable sutures dominate the GCC surgical sutures market with a market share of 70%, primarily as they dissolve naturally within the body, eliminating post-operative removal visits and reducing the per-episode cost of care, a priority for hospital networks expanding under Saudi Vision 2030. The region's acute burden of obesity and diabetes, with Saudi Arabia reporting adult obesity rates exceeding 35 percent, directly drives high volumes of bariatric, metabolic, and abdominal surgeries where absorbable sutures are the clinical standard. Synthetic variants lead within this segment owing to their predictable absorption timelines and minimal tissue reaction, qualities that align with Joint Commission International accreditation standards pursued by flagship hospitals in Riyadh, Dubai, and Doha.

Ethicon, operating under J&J MedTechAdvanced Medical Solutions further consolidated the competitive landscape by completing the acquisition of Peters Surgical in July 2024, expanding its absorbable suture manufacturing capacity and global distribution network. Absorbable sutures will sustain leadership through 2032 as antibacterial innovation and rising surgical volumes reinforce their clinical and commercial primacy across the GCC. By product type, the market is further segmented into the following sub-categories:

, reinforced this segment's commercial trajectory in early 2024 by discontinuing 197 non-antibacterial synthetic absorbable suture codes to concentrate its portfolio on VICRYL Plus Antibacterial technology, which clinical evidence associates with a nearly 30 percent reduction in surgical site infection risk. Based on product type, the market is bifurcated into:

• Surgical Staplers
• Tissue Adhesives & Sealants
• Wound Closure Strips
• Surgical Clips
• Surgical Sutures
• Others

General Surgery Dominates the GCC Wound Closure Devices Market Due to High Procedure Volumes and Expanding Hospital Infrastructure

General surgery commands the largest application share with 35%; it spans the broadest procedural range: hernia repair, appendectomy, cholecystectomy, and bariatric surgery, among others, and operates across every tier of the hospital network, from large government medical cities to private day-surgery centres. No other specialty matches this institutional reach. Saudi Arabia's commitment of USD 57.1 billion to health and social development in 2024, prioritizing new hospital construction and healthcare services expansion, directly increases the number of general surgery units procuring sutures at scale.

More significantly, in June 2025, B. Braun launched a next-generation polyglactin 910 suture line under its surgical portfolio, offering improved handling characteristics and a faster absorption profile, a direct product response to growing demand from general surgery departments requiring versatile, faster-resorbing closure materials. This launch signals B. Braun's deliberate reinforcement of its general surgery positioning at a time when GCC hospital networks are expanding procedure capacity under Vision 2030 infrastructure commitments. By application, the market is further segmented into the following sub-categories:

• General Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Gynecological & Obstetric Surgery
• Ophthalmic Surgery
• Cosmetic & Plastic Surgery
• Neurological Surgery
• Others

GCC Wound Closure Devices Geographical Analysis

Saudi Arabia accounts for approximately 39% of the GCC wound closure devices market, making it by far the dominant country in the region. This position is anchored by the Kingdom's unmatched hospital network scale and surgical output. According to Saudi Arabia's General Authority for Statistics 2024 Healthcare Establishments and Workforce Statistics publication, the total number of hospitals in the Kingdom reached 516 in 2024, with Riyadh Region alone housing 115 hospitals supported by 5,779 primary healthcare centres and a physician workforce of 129,772, up 14.54% from 2023.

Each hospital generates recurring procurement demand for sutures and wound closure consumables across every surgical episode. At the facility level, Saudi Arabia's Ministry of National Guard Health Affairs reported 59,029 surgeries performed across its hospital network in 2024 alone, illustrating the depth of operative volume flowing through even a single public healthcare system within the Kingdom.

Looking ahead, King Salman Medical City in Madinah expanded its specialised centres in 2025, covering oncology, cardiology, diabetes, neurosciences, and ophthalmology while treating 931,745 beneficiaries in the first half of 2025 alone, directly reflecting the growing operative throughput that sustains Saudi Arabia's dominant position in GCC surgical sutures and wound closure device procurement through 2032.

GCC Wound Closure Devices Market Competitive Landscape

The GCC wound closure devices market is characterized by a fragmented market structure, with the presence of several multinational and regional manufacturers competing across absorbable and non-absorbable suture categories. The market is led by major players such as Ethicon US, LLC, Medtronic plc, B. Braun Melsungen SE, Smith & Nephew plc, and Advanced Medical Solutions Group plc. Collectively, these top five companies account for approximately 22% of the total market share.

Major Players in the GCC Wound Closure Devices Market

• Ethicon US, LLC
• Medtronic plc
• B. Braun Melsungen SE
• Smith & Nephew plc
• Teleflex Incorporated
• Advanced Medical Solutions Group plc
• ConvaTec Group PLC
• Corza Medical, Inc.
• Meril Life Sciences Pvt. Ltd.
• Healthium Medtech Limited
• Peters Surgical SAS
• Deme TECH Corporation

GCC Wound Closure Devices News and Recent Developments

2026: Tamer Mölnlycke Care Doubles Wound Care Manufacturing Capacity at Jeddah Third Industrial City

Saudi Minister of Industry Bandar Alkhorayef inaugurated the second phase of the Tamer Mölnlycke Care factory at Jeddah's Third Industrial City in January 2026, as confirmed by Modon. The expansion doubled annual production capacity to 500,000 units per year. The facility, a joint venture between Mölnlycke Health Care (60% majority stake) and Saudi Tamer Group, manufactures surgical procedure trays, wound care products, and surgical drapes for GCC and MENA distribution. Phase I had commenced just 12 months earlier.

Impact Analysis: Doubling in-Kingdom wound care production strengthens regional supply chain resilience for surgical consumables and positions Tamer Mölnlycke Care as a NUPCO-eligible local supplier. This compresses delivery lead times to Saudi government hospitals and raises direct competitive pressure on import-only suppliers whose procurement eligibility is increasingly constrained by Saudi localization requirements.

2025: KFSHRC Performs World's First Robotic-Assisted Artificial Heart Pump Implantation in Riyadh

King Faisal Specialist Hospital and Research Centre performed the world's first robotic-assisted Abbott HeartMate 3 artificial heart pump implantation on 16 January 2025 in Riyadh. The patient — hospitalised for 120 days — spent just 4 days in ICU post-surgery versus the 26-day conventional average, with discharge at 10 days against the standard 63. KFSHRC performed 1,370 robotic procedures in 2024, a 28% year-on-year increase, and ranks 15th globally among the top 250 academic medical centres for 2025.

Impact Analysis: KFSHRC's 28% annual growth in robotic procedures signals a structural shift toward minimally invasive surgery across Saudi Arabia's leading tertiary hospitals. Robotic techniques require specialised fine-gauge and absorbable suture formats, driving procurement migration toward higher-specification wound closure products and expanding per-procedure revenue contribution across the GCC market.

2025: KFSHRC and NUPCO Sign MoU to Strengthen Saudi Arabia's Medical Supply and Procurement Chain

Under the patronage of Saudi Minister of Health Fahad Al-Jalajel, King Faisal Specialist Hospital and Research Centre signed a Memorandum of Understanding with NUPCO — Saudi Arabia's PIF-owned centralised procurement company — on 30 June 2025 in Riyadh. The MoU covers 5 cooperation areas: development of NUPCO's digital procurement marketplace, unification of product catalogues across 47 government health agencies, logistics enhancement, clinical service alignment, and AI application in procurement. NUPCO currently procures 7,919 medical items annually and secured SAR 2.5 billion in financing in early 2025.

Impact Analysis: Integrating KFSHRC's clinical procurement systems with NUPCO's centralised supply platform creates a unified demand visibility framework across Saudi Arabia's largest specialist hospital and the Kingdom's primary medical procurement channel. For wound closure device suppliers, unified product catalogues mean standardised procurement pathways and increased volume predictability, while AI-driven procurement signals earlier demand forecasting across government hospital networks.

2025: NUPCO Secures USD 667 million in Supply Chain Financing to Strengthen Medical Device Distribution Across Saudi Arabia

At the 2025 PIF Private Sector Forum in Riyadh, Saudi Arabia's National Unified Procurement Company (NUPCO) signed four financing agreements totalling SAR 2.5 billion (USD 667 million) with Banque Saudi Fransi (SAR 500 million), First Abu Dhabi Bank (SAR 1 billion), and Tameed (SAR 1 billion). The capital is allocated to strengthen supply chain financing for healthcare suppliers, improving their access to working capital. NUPCO simultaneously signed 6 logistics MoUs with Aramex, DHL, UPS, and SMSA to extend last-mile medical device delivery to over 300 hospitals and 2,500 clinics serving 97% of Saudi Arabia.

Impact Analysis: Injecting USD 667 million into NUPCO's supplier financing infrastructure directly improves cash flow for wound closure device distributors supplying Saudi government hospitals, reducing supply disruption risk. The simultaneous expansion of last-mile logistics partnerships with four global operators strengthens delivery reliability across all 13 Saudi regions, sustaining consistent procurement throughput for surgical consumables, including sutures and wound closure devices.